| Tag | Content |
|---|
EnhancerAtlas ID | HS139-22422 |
Organism | Homo sapiens |
Tissue/cell | Myotube |
Coordinate | chr17:15861950-15862800 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| GATA2 | MA0036.3 | chr17:15862369-15862380 | AAAGATAAGAA | - | 6.62 | | RUNX1 | MA0002.2 | chr17:15862627-15862638 | GTTTGTGGTTT | + | 6.02 | | SPIC | MA0687.1 | chr17:15862048-15862062 | TTCTTCCCCATTTT | - | 6.04 |
|
| | Number of super-enhancer constituents: 6 | ID | Coordinate | Tissue/cell |
| SE_10130 | chr17:15861220-15863632 | CD14 | | SE_34155 | chr17:15861525-15863662 | HCC1954 | | SE_34419 | chr17:15858959-15864051 | HCT-116 | | SE_47449 | chr17:15859002-15863694 | Panc1 | | SE_50867 | chr17:15861659-15862574 | Sigmoid_Colon | | SE_64592 | chr17:15861503-15863579 | NHEK |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH17I015955 | chr17 | 15859200 | 15863612 |
|
Enhancer Sequence | GGACCCCTCT CAATTCCTGA GACTTCTGGA GCTCAGGCCT TTGCGCATGT GTTTCCCTCT 60
GCCTGCGGTG ACCTTCTCTC TATCTCTTTG CCTGCTGATT CTTCCCCATT TTCTCTGTGC 120
CCCTGAAAAT GACACTCCCT CTGGGGGGCA CACAGGGTTC TTTTGCAGCT CTCTGCATAC 180
TTGCAGCTCT TTTCTTAATT ATTTGTAATT TGTTTAAGGT TTGCCATCCT TTCTCTGTTA 240
TGAGCAGGGC ACATGTCTGT TGCTTTCTCA TTATCCCCTG TGTGTTGTCC AGTCACTGGC 300
TTGGCTTGTG ACATATTAAG AGTCGGCAGT ATACATGTGC ATGCAAATGT ATGAACATGT 360
GTCTCTGTGT GTGTATAATC GGGGGTGGGA TTAGCTCTGA ACCGATGAGC TTGTTGCCTA 420
AAGATAAGAA TCCCACATCG TGTGTCCTGA GAGGAGAGAT AGGAGAAACT GAAGAGGCCA 480
AAAAGCTAGA CTGGCTTCAC TAAAACCAGC AGGGAGACTT TGATGGGGAA TGGTTAGCAG 540
TGTTACAGAG GGATAAAATG CCTCCTAAAT TTGGCATTTT CAGAAGTCAT TTAGCAACCT 600
AGTCTTTTAA TTGCAGGGAT TTTTTAAAAA TTACAAAATG AGTACAGTAC ATATTTGTAT 660
CTGACTCATC TAACGAAGTT TGTGGTTTCA GAAATAATGA GTCATTCTGA AACAGTGTAT 720
TGTTTCACAG CTTTTAAGTT GCATGACTAA TACAGTGCAT TACTATATAC CTTTCACTTA 780
CATTCACAAA TTATGAATAG TTTGCTACAT TTGGTTTGTC TCACACACAC ATACACTGGC 840
ACAATGATCA 850
|
